{"id":"https://openalex.org/W2070515744","doi":"https://doi.org/10.1254/jphs.09124fp","title":"Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate","display_name":"Assessment of Binding Affinity to 5-Hydroxytryptamine 2A (5-HT2A) Receptor and Inverse Agonist Activity of Naftidrofuryl: Comparison With Those of Sarpogrelate","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2070515744","doi":"https://doi.org/10.1254/jphs.09124fp","mag":"2070515744","pmid":"https://pubmed.ncbi.nlm.nih.gov/19672037"},"language":"en","primary_location":{"id":"doi:10.1254/jphs.09124fp","doi":"https://doi.org/10.1254/jphs.09124fp","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.09124fp","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/110/4/110_09124FP/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2070515744"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/jphs/110/4/110_09124FP/_pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011489304","display_name":"Saida A. Aly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114838220","display_name":"Niigata University of Pharmacy and Medical and Life Sciences","ror":"https://ror.org/00dnbtf70","country_code":"JP","type":"education","lineage":["https://openalex.org/I114838220"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Saida Abdel Regal Aly","raw_affiliation_strings":["Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan","Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan","institution_ids":["https://openalex.org/I114838220"]},{"raw_affiliation_string":"Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan","institution_ids":["https://openalex.org/I114838220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066636368","display_name":"Murad Hossain","orcid":"https://orcid.org/0000-0002-3680-6511","observed_orcids":["https://orcid.org/0000-0002-3680-6511"]},"institutions":[{"id":"https://openalex.org/I114838220","display_name":"Niigata University of Pharmacy and Medical and Life Sciences","ror":"https://ror.org/00dnbtf70","country_code":"JP","type":"education","lineage":["https://openalex.org/I114838220"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Murad Hossain","raw_affiliation_strings":["Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan","institution_ids":["https://openalex.org/I114838220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013379911","display_name":"Mohiuddin Ahmed Bhuiyan","orcid":"https://orcid.org/0000-0002-2218-4061","observed_orcids":["https://orcid.org/0000-0002-2218-4061"]},"institutions":[{"id":"https://openalex.org/I114838220","display_name":"Niigata University of Pharmacy and Medical and Life Sciences","ror":"https://ror.org/00dnbtf70","country_code":"JP","type":"education","lineage":["https://openalex.org/I114838220"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mohiuddin Ahmed Bhuiyan","raw_affiliation_strings":["Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan","institution_ids":["https://openalex.org/I114838220"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086485936","display_name":"Takashi Nakamura","orcid":"https://orcid.org/0000-0003-0326-1903","observed_orcids":["https://orcid.org/0000-0003-0326-1903"]},"institutions":[{"id":"https://openalex.org/I114838220","display_name":"Niigata University of Pharmacy and Medical and Life Sciences","ror":"https://ror.org/00dnbtf70","country_code":"JP","type":"education","lineage":["https://openalex.org/I114838220"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Nakamura","raw_affiliation_strings":["Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan","institution_ids":["https://openalex.org/I114838220"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110249928","display_name":"Takafumi Nagatomo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114838220","display_name":"Niigata University of Pharmacy and Medical and Life Sciences","ror":"https://ror.org/00dnbtf70","country_code":"JP","type":"education","lineage":["https://openalex.org/I114838220"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takafumi Nagatomo","raw_affiliation_strings":["Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, Japan","institution_ids":["https://openalex.org/I114838220"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114838220"],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":null,"fwci":0.3218,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.51177353,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"110","issue":"4","first_page":"445","last_page":"450"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/naftidrofuryl","display_name":"naftidrofuryl","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sarpogrelate","display_name":"sarpogrelate","score":0.9660000205039978},{"id":"https://openalex.org/keywords/5-ht2a-receptor","display_name":"5-HT2A receptor","score":0.9940000176429749},{"id":"https://openalex.org/keywords/serotonin-receptors","display_name":"serotonin receptors","score":0.625},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.8119999766349792},{"id":"https://openalex.org/keywords/peripheral-vasodilators","display_name":"peripheral vasodilators","score":0.8889999985694885}],"concepts":[{"id":"https://openalex.org/C89951826","wikidata":"https://www.wikidata.org/wiki/Q1671731","display_name":"Inverse agonist","level":4,"score":0.7922098636627197},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.757086992263794},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6961393356323242},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6389732360839844},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5531882643699646},{"id":"https://openalex.org/C160262196","wikidata":"https://www.wikidata.org/wiki/Q5376331","display_name":"Endogenous agonist","level":5,"score":0.43307042121887207},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21224141120910645},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19612115621566772},{"id":"https://openalex.org/C120750228","wikidata":"https://www.wikidata.org/wiki/Q2035393","display_name":"Dopamine receptor D1","level":4,"score":0.044497787952423096}],"mesh":[{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009257","descriptor_name":"Nafronyl","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013386","descriptor_name":"Succinates","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D021381","descriptor_name":"Protein Transport","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054314","descriptor_name":"Drug Inverse Agonism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058826","descriptor_name":"Serotonin 5-HT2 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058830","descriptor_name":"Serotonin 5-HT2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1254/jphs.09124fp","doi":"https://doi.org/10.1254/jphs.09124fp","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.09124fp","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/110/4/110_09124FP/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:19672037","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19672037","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacological sciences","raw_type":"Comparative Study"},{"id":"pmh:oai:doaj.org/article:f472e63f0f6c46c7be0d6b6cc29ed535","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f472e63f0f6c46c7be0d6b6cc29ed535","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacological Sciences, Vol 110, Iss 4, Pp 445-450 (2009)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1254/jphs.09124fp","doi":"https://doi.org/10.1254/jphs.09124fp","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.09124fp","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/110/4/110_09124FP/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2070515744.pdf","grobid_xml":"https://content.openalex.org/works/W2070515744.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W62549861","https://openalex.org/W112053250","https://openalex.org/W1491380749","https://openalex.org/W1775749144","https://openalex.org/W1972968028","https://openalex.org/W1974049103","https://openalex.org/W1988269241","https://openalex.org/W1998462973","https://openalex.org/W2024773645","https://openalex.org/W2025251707","https://openalex.org/W2046787882","https://openalex.org/W2052499056","https://openalex.org/W2052889654","https://openalex.org/W2087150828","https://openalex.org/W2103188546","https://openalex.org/W2140136269","https://openalex.org/W2143957256","https://openalex.org/W2144985796","https://openalex.org/W2149089744","https://openalex.org/W2156696484","https://openalex.org/W2162328027","https://openalex.org/W2171134406","https://openalex.org/W2279919674","https://openalex.org/W2323066513","https://openalex.org/W2334356124","https://openalex.org/W2340033460","https://openalex.org/W2405848351","https://openalex.org/W2462758610","https://openalex.org/W4236938366"],"related_works":["https://openalex.org/W2012502056","https://openalex.org/W3041544015","https://openalex.org/W2052499056","https://openalex.org/W2064924029","https://openalex.org/W119276586","https://openalex.org/W3098601524","https://openalex.org/W2462589785","https://openalex.org/W2186259158","https://openalex.org/W2052889654","https://openalex.org/W2412060707"],"abstract_inverted_index":{"Naftidrofuryl":[0],"is":[1,38],"a":[2,64],"peripheral":[3],"vasodilator":[4],"that":[5,84],"has":[6,19],"been":[7],"clinically":[8],"used":[9],"in":[10,99],"the":[11,29,35,41,50,56,75,85,100,110,123,139,145,148,156,172,179],"treatment":[12],"of":[13,34,47,60,68,79,89,114,131,147,158,161,174],"intermittent":[14],"claudication":[15],"and":[16,25,44,71,166],"dementia.":[17],"It":[18],"5-hydroxytryptamine":[20],"2":[21],"(5-HT(2))":[22],"antiserotonergic":[23],"activity":[24,59,130,177],"selectively":[26],"binds":[27],"with":[28,77,136],"5-HT(2)":[30],"receptor.":[31,125,143,183],"The":[32,81],"purpose":[33],"present":[36,149],"study":[37,150],"to":[39,49,53,73,97,120,163,170],"assess":[40],"binding":[42,86],"affinity":[43,87],"functional":[45,111],"potency":[46,112],"naftidrofuryl":[48,90,115,132,162],"5-HT(2A)":[51,69,102,124,164],"receptor,":[52,70,107],"find":[54],"out":[55],"inverse":[57,128,175],"agonist":[58,129,176],"this":[61],"compound":[62],"at":[63,122,138,178],"constitutively":[65,140,180],"active":[66,141,181],"mutant":[67,106,142,182],"finally":[72],"compare":[74],"findings":[76],"those":[78],"sarpogrelate.":[80],"investigation":[82],"showed":[83],"(pK(i))":[88],"was":[91,116,133],"decreased":[92],"25-":[93],"or":[94,104],"50-fold":[95],"compared":[96,119,135],"sarpogrelate":[98,121,137],"wild-type":[101],"receptor":[103],"Cys322Lys":[105],"respectively.":[108],"Moreover,":[109],"(pK(b))":[113],"much":[117],"lower":[118,134],"In":[126],"addition,":[127],"Thus,":[144],"data":[146],"would":[151],"be":[152],"very":[153],"important":[154],"for":[155],"clarification":[157],"interaction":[159],"sites":[160],"receptors":[165],"also":[167],"may":[168],"help":[169],"understand":[171],"mechanism":[173]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}